VExUS Combined With CVP to Predict Clinical Outcomes in Sepsis Participants — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

VExUS Combined With CVP to Predict Clinical Outcomes in Sepsis Participants — Stella

Recruiting

Back to Sepsis trials

Trial locations(1 site)

China

Point-of-care ultrasound (POCUS), Yibin, Sichuan

Key details

Sponsor

The Second People's Hospital of Yibin

Enrollment target

~120 participants

Started

July 2024

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 100 Years

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov